In the world, and could also lead to treatments for other life-threatening blood diseases, such as sickle-cell anemia. This combination isĪimed at treating and, possibly, curing Alpha Thalassemia Major, a blood disease that is often fatal in utero. That will test the safety of combining in utero hematopoietic stem cell transplant with a fetal transfusion of red blood cells. UCSF Benioff Children's Hospital Oakland and the Center for Maternal-Fetal Precision Medicine have begun enrollment for a clinical trial Intrauterine Therapy for Alpha Thalassemia Major: We aim to integrate resources and talent between scientists and clinicians to accelerate research and clinical trials of fetal and neonatal interventions,Ĭreate stronger bridges between basic research and clinical applications, and improve maternal, fetal, and neonatal care. The Center for Maternal-Fetal Precision Medicine is a trans-disciplinary program designed to improve our understanding and treatment of patients with congenital anomalies and pregnancy complications. MacKenzie UCSF Fetal Treatment Center: 1-800-RX-FETUS. Physicians and families who would like more information about our program and treatment for their family, please contact: 'Focus on Alpha Thalassemia' by Ash Lal MD ▶ Perinatal Treatment: IUT and stem cell transplant "Surviving with Joy: Living with Alpha Thalassemia Major", a film by the UCSF Fetal Treatment Center Thalassemia at UCSF Benioff Children's Hospital Oakland Intrauterine Therapy Program Intrauterine Therapy for Alpha Thal Major.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |